Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Brawn Biotech Ltd has submitted a compliance certificate from its Registrar and Share Transfer Agent, RCMC Share Registry Pvt Ltd, confirming that securities submitted for dematerialisation during Q4 FY 2025-26 (January to March 2026) were properly processed. The certificate verifies that physical share certificates received for dematerialisation were mutilated and cancelled, and the names of depositories were substituted in the register of members within the required 15-day timeframe. This is a routine regulatory filing required under SEBI regulations to confirm proper handling of share dematerialisation requests.
This is a standard compliance filing with no direct impact on the company's financials or stock price. It simply confirms that the dematerialisation process was carried out correctly by the registrar. Shareholders who converted physical shares to electronic form during this quarter had their requests processed within the mandated timeframe.